Akoya Biosciences, Inc. financial data

Symbol
AKYA on Nasdaq
Industry
Laboratory Analytical Instruments
Location
100 Campus Drive, 6 Th Floor, Marlborough, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 302 % -3.35%
Quick Ratio 70.3 % +57.6%
Debt-to-equity 398 % +102%
Return On Equity -189 % -55.6%
Return On Assets -38.1 % +7.12%
Operating Margin -58.1 % +19.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.6M shares +0.99%
Common Stock, Shares, Outstanding 49.5M shares +1.44%
Entity Public Float 186M USD -15.9%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 49.5M shares +1.08%
Weighted Average Number of Shares Outstanding, Diluted 49.5M shares +1.08%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 86.8M USD -4.98%
Cost of Revenue 36.7M USD -7.39%
Research and Development Expense 17.6M USD -32.5%
Operating Income (Loss) -50.5M USD +23.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -57.8M USD +19%
Income Tax Expense (Benefit) 132K USD +267%
Net Income (Loss) Attributable to Parent -58M USD +18.8%
Earnings Per Share, Basic -1.13 USD/shares +35.4%
Earnings Per Share, Diluted -1.13 USD/shares +35.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12.6M USD -84%
Marketable Securities, Current 23.3M USD
Cash, Cash Equivalents, and Short-term Investments 39.3M USD
Accounts Receivable, after Allowance for Credit Loss, Current 12.8M USD -20.6%
Inventory, Net 25.2M USD +34.5%
Other Assets, Current 2.97M USD -15.4%
Assets, Current 76.9M USD -34.3%
Property, Plant and Equipment, Net 7.55M USD -30.4%
Operating Lease, Right-of-Use Asset 4.66M USD -48.2%
Intangible Assets, Net (Excluding Goodwill) 15.3M USD -15.7%
Goodwill 18.3M USD 0%
Other Assets, Noncurrent 731K USD +11.8%
Assets 130M USD -26.7%
Accounts Payable, Current 8.76M USD -26.3%
Employee-related Liabilities, Current 4.26M USD -38.8%
Accrued Liabilities, Current 9.37M USD -29%
Contract with Customer, Liability, Current 6.19M USD -9.66%
Liabilities, Current 28M USD -21.2%
Contract with Customer, Liability, Noncurrent 3.09M USD +11.2%
Deferred Income Tax Liabilities, Net 113K USD +29.9%
Operating Lease, Liability, Noncurrent 4.56M USD -32.4%
Other Liabilities, Noncurrent 40K USD -71.4%
Liabilities 116M USD +0.93%
Accumulated Other Comprehensive Income (Loss), Net of Tax 8K USD
Retained Earnings (Accumulated Deficit) -277M USD -26.4%
Stockholders' Equity Attributable to Parent 13.6M USD -78%
Liabilities and Equity 130M USD -26.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.8M USD -5.4%
Net Cash Provided by (Used in) Financing Activities -444K USD -5.97%
Net Cash Provided by (Used in) Investing Activities -48.8M USD -888%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 49.5M shares +0.94%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -70.1M USD -401%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13.2M USD -83.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.24M USD +25.1%
Deferred Tax Assets, Valuation Allowance 51.4M USD +35.6%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 53.5M USD +30.2%
Operating Lease, Liability 7.21M USD -24.4%
Payments to Acquire Property, Plant, and Equipment 810K USD +0.75%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -58M USD +18.7%
Lessee, Operating Lease, Liability, to be Paid 8.18M USD -26.7%
Property, Plant and Equipment, Gross 18.1M USD -7.52%
Operating Lease, Liability, Current 2.65M USD -4.98%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.62M USD -7.78%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.78M USD +0.22%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 37K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 962K USD -40.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.1M USD -58.1%
Deferred Tax Assets, Operating Loss Carryforwards 31.4M USD +17.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 9.14M USD +22.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 436K USD -60.5%
Operating Lease, Payments 718K USD -4.65%
Additional Paid in Capital 291M USD +3.42%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2.05M USD -3.3%
Deferred Tax Assets, Net of Valuation Allowance 2.14M USD -33.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%